Showing 1-10 of 37 results for "".

• Alexis Buffington, BS
  https://practicaldermatology.com/profiles/alexis-buffington-bs/Lom41V/

• Cutaneous Metastasis of Adenocarcinoma with an Unknown Primary Tumor

  https://practicaldermatology.com/youngmd-connect/resident-resource-center/cutaneous-metastasis-of-adenocarcinoma-with-an-unknown-primary-tumor/20352/
  Report and discussion: Cutaneous metastasis of adenocarcinoma with an unknown primary tumor.
  • Text

• Andrew F. Alexis, MD, MPH

  https://practicaldermatology.com/topics/general-topics/andrew-f-alexis-md-mph/21369/
  • Text

• Can UV Nail Dryers Cause Skin Cancer?

  https://practicaldermatology.com/topics/hair-nails/can-uv-nail-dryers-cause-skin-cancer/23898/
  Alexis Livingston Young, MD, weighs in on the evidence.
  • Text

• Dispatches from the 2022 Skin of Color Update

  https://practicaldermatology.com/conferences/skin-of-color-update-2022/dispatches-from-the-2022-skin-of-color-update/23822/
  Co-chair Dr. Andrew F. Alexis shares highlights from the recent meeting.
  • Text

• Photoprotection in Diverse Patient Populations

  https://practicaldermatology.com/programs/practical-dermatology/photoprotection-in-diverse-patient-populations/18196/
  In part one of a three-part podcast series on dermatologic issues facing patients with darker skin tones, Drs. Andrew Alexis, Corey Hartman, and Janiene Luke discuss photoprotection and why it matters for all patients. 
  • Audio
  • Podcast

• Laser hair removal in darker skin types, challenges and technological advances for treatment

  https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/laser-hair-removal-in-darker-skin-types-challenges-and-technological-advances-for-treatment/18800/
  Andrew Alexis, MD discusses laser hair removal treatment challenges in patients with higher Fitzpatrick skin types, and how recent advances in technology have been able to address these to deliver effective treatment with minimal pain.
  • Video

• FDA Approves Eli Lilly’s AD Drug Ebglyss (Lebrikizumab)

  https://practicaldermatology.com/series/dermwire-tv/fda-approves-eli-lillys-ad-drug-ebglyss-lebrikizumab/28645/
  In this week's DermwireTV, Andrew F. Alexis, MD, Professor of Clinical Dermatology at Weill Cornell Medical College, discusses the newly approved AD drug lebrikizumab; LEO Pharma announces two major regulatory milestones for its chronic hand eczema (CHE) treatment; and the CMO of Arcutis Bioteherapu
  • Video

• Evaluating Lebrikizumab in Pigmented Skin

  https://practicaldermatology.com/series/updates-atopic-dermatitis/evaluating-lebrikizumab-in-pigmented-skin/36490/
  Andrew Alexis, MD, MPH, discusses new data presented at the Revolutionizing Atopic Dermatitis (RAD) Conference from the phase 3b Admirable trial, the first dedicated study for evaluating the efficacy and safety of Lilly's FDA-approved medicine in adult and adolescent patients with pigmented skin and
  • Video

• The Use of Lasers and Energy-Based Devices in Patients with Richly Pigmented Skin

  https://practicaldermatology.com/programs/practical-dermatology/the-use-of-lasers-and-energy-based-devices-in-patients-with-richly-pigmented-skin/18199/
  In the last of a three-part podcast series on dermatologic issues facing patients with darker skin tones, Andrew Alexis, MD, a dermatologist from New York City and the President of the Skin of Color Society, Corey Hartman, MD, a dermatologist in Birmingham, Alabama, and Janiene Luke, MD, a dermatolo
  • Audio
  • Podcast

• Prev
• 1
• 2
• 3
• 4
• Next